BR0013106A - Composição farmacêutica flutuante, comprimido, e processo de prepapação de um comprimido. - Google Patents

Composição farmacêutica flutuante, comprimido, e processo de prepapação de um comprimido.

Info

Publication number
BR0013106A
BR0013106A BR0013106-7A BR0013106A BR0013106A BR 0013106 A BR0013106 A BR 0013106A BR 0013106 A BR0013106 A BR 0013106A BR 0013106 A BR0013106 A BR 0013106A
Authority
BR
Brazil
Prior art keywords
tablet
pharmaceutical composition
preparation process
floating
floating pharmaceutical
Prior art date
Application number
BR0013106-7A
Other languages
English (en)
Inventor
Jerome Besse
Original Assignee
Galenix Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galenix Dev filed Critical Galenix Dev
Publication of BR0013106A publication Critical patent/BR0013106A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Saccharide Compounds (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA FLUTUANTE, COMPRIMINDO, E PROCESSO DE PREPARAçãO DE UM COMPRIMIDO". A presente invenção refere-se a uma composição farmacêutica flutuante constituída por pelo menos uma primeira fase compreendendo pelo menos um princípio ativo fortemente dosado em associação com um ou vários excipientes e pelo menos uma segunda fase compreendendo pelo menos um sistema gerador de gás. A invenção também se refere a comprimidos compreendendo uma tal composição farmacêutica assim como um processo de preparação de tais comprimidos.
BR0013106-7A 1999-08-06 2000-08-02 Composição farmacêutica flutuante, comprimido, e processo de prepapação de um comprimido. BR0013106A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9910285A FR2797185B1 (fr) 1999-08-06 1999-08-06 Composition pharmaceutique flottante comprenant une phase active et une phase non active
PCT/FR2000/002223 WO2001010417A1 (fr) 1999-08-06 2000-08-02 Composition pharmaceutique flottante comprenant une phase active et une phase non active

Publications (1)

Publication Number Publication Date
BR0013106A true BR0013106A (pt) 2002-07-23

Family

ID=9548990

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0013106-7A BR0013106A (pt) 1999-08-06 2000-08-02 Composição farmacêutica flutuante, comprimido, e processo de prepapação de um comprimido.

Country Status (12)

Country Link
US (1) US7682629B1 (pt)
EP (1) EP1206247B1 (pt)
AT (1) ATE450254T1 (pt)
AU (1) AU779036B2 (pt)
BR (1) BR0013106A (pt)
CA (1) CA2378988C (pt)
DE (1) DE60043442D1 (pt)
FR (1) FR2797185B1 (pt)
HU (1) HUP0202764A3 (pt)
IL (2) IL148003A0 (pt)
NO (1) NO20020572L (pt)
WO (1) WO2001010417A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2325152C2 (ru) 2001-07-04 2008-05-27 Сан Фармасьютикл Индастриз Лимитид Удерживаемая в желудке система регулируемой доставки лекарственного средства
NZ536273A (en) * 2002-12-20 2007-08-31 Hoffmann La Roche High dose ibandronate formulation
TW200533391A (en) 2004-03-25 2005-10-16 Sun Pharmaceutical Ind Ltd Gastric retention drug delivery system
BRPI0615410A2 (pt) * 2005-08-30 2013-02-13 Nicholas Piramal India Ltd composiÇço farmacÊutica de liberaÇço prolongada de metformina e processo para produÇço da mesma
JP5545952B2 (ja) * 2007-08-31 2014-07-09 第一三共株式会社 徐放性製剤及びその製造方法
JP2012500230A (ja) 2008-08-18 2012-01-05 北京天衡▲薬▼物研究院 胃内滞留薬物放出システム及びその製造方法と使用
FR2938431B1 (fr) 2008-11-14 2013-12-20 Debregeas Et Associes Pharma Nouvelle composition a base d'acide gamma-hydroxybutyrique
FR2949061B1 (fr) 2009-08-12 2013-04-19 Debregeas Et Associes Pharma Microgranules flottants
FR2949062B1 (fr) 2009-08-12 2011-09-02 Debregeas Et Associes Pharma Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
FR2967352B1 (fr) * 2010-11-12 2012-12-28 Unither Dev Comprime effervescent pour l'administration par voie orale de principes actifs
WO2015089420A1 (en) 2013-12-13 2015-06-18 Biogen Idec Ma Inc. Controlled release dosage form for once daily administration of dimethyl fumarate
WO2019126218A1 (en) * 2017-12-18 2019-06-27 Tris Pharma, Inc. Modified release drug powder composition comprising gastro-retentive raft forming systems having trigger pulse drug release
WO2019126216A1 (en) 2017-12-18 2019-06-27 Tris Phama, Inc. Pharmaceutical compositions comprising a floating interpenetrating polymer network forming system
EP3737353A1 (en) 2017-12-18 2020-11-18 Tris Pharma, Inc. Ghb pharmaceutical compositions comprising a floating interpenetrating polymer network forming system
US11337920B2 (en) 2017-12-18 2022-05-24 Tris Pharma, Inc. Pharmaceutical composition comprising GHB gastro-retentive raft forming systems having trigger pulse drug release
JP2026513019A (ja) 2023-02-03 2026-04-22 トリス・フアルマ・インコーポレーテツド 1晩1回の低ナトリウムオキシベート組成物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
JPS62195323A (ja) 1986-02-24 1987-08-28 Eisai Co Ltd 胃内滞留型粒子
DE3803482A1 (de) * 1988-02-05 1989-08-17 Lohmann Therapie Syst Lts Schwimmfaehiges orales therapeutisches system
DE4403943A1 (de) * 1994-02-08 1995-08-10 Hexal Pharma Gmbh Orale Azrneimittelzubereitung mit Diclofenac-Natrium
DE4406424A1 (de) * 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
US5783212A (en) * 1996-02-02 1998-07-21 Temple University--of the Commonwealth System of Higher Education Controlled release drug delivery system
IT1282650B1 (it) * 1996-02-19 1998-03-31 Jagotec Ag Compressa farmaceutica,caratterizzata da elevato aumento di volume a contatto con liquidi biologici
FR2766708B1 (fr) * 1997-07-30 2000-05-05 Galenix Dev Composition contenant de l'hydroxypropylcellulose, de l'hydroxypropylmethylcellulose et/ou de l'ethylcellullose a titre d'agents desintegrants, et procede d'obtention
US6197328B1 (en) * 1999-08-20 2001-03-06 Dott Research Laboratory Nasally administrable compositions

Also Published As

Publication number Publication date
HUP0202764A2 (hu) 2003-01-28
NO20020572L (no) 2002-04-03
FR2797185B1 (fr) 2001-10-26
WO2001010417A1 (fr) 2001-02-15
IL148003A (en) 2007-06-03
US7682629B1 (en) 2010-03-23
CA2378988A1 (fr) 2001-02-15
EP1206247A1 (fr) 2002-05-22
EP1206247B1 (fr) 2009-12-02
IL148003A0 (en) 2002-09-12
FR2797185A1 (fr) 2001-02-09
CA2378988C (fr) 2012-04-17
ATE450254T1 (de) 2009-12-15
NO20020572D0 (no) 2002-02-05
AU779036B2 (en) 2005-01-06
HUP0202764A3 (en) 2004-05-28
DE60043442D1 (de) 2010-01-14
AU6848700A (en) 2001-03-05

Similar Documents

Publication Publication Date Title
MXPA03007712A (es) Sales farmaceuticas.
HUP0302131A2 (hu) Gyógyászati tramadolsók, ezeket tartalmazó gyógyszerkészítmények
GEP20053473B (en) High Potency Dihydroergotamine Compositions
SE0001899D0 (sv) New compounds
EP1049459A4 (en) ORAL LIQUID COMPOSITIONS
GT199900203A (es) Composiciones de celecoxib.
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
PT1126828E (pt) Administração oral de análogos de adenosina
YU57600A (sh) Derivarti biciklične hidroksaminske kiseline
AU9163701A (en) Topical composition containing at least one vitamin D or one vitamin D analogue and at least one corticosteroid
NZ516347A (en) Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them
AU2084801A (en) Antiviral medication
MY141243A (en) Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-ii diabetes mellitus
WO2004032909A3 (en) Stabilized pharmaceutical composition containing basic excipients
DE60024491D1 (de) Schnell-wirkende, gefrier-trocknete, orale, pharmazeutische formulierung für die behandlung von migräne
HUT51269A (en) Process for producing benzimidazole derivatives and pharmaceutical compositions comprising same
IL150528A0 (en) Ibuprofen containing active agent preparation
HK1041816A1 (zh) 药片
GR1002847B (el) Χρηση της μισοπροστολης ή/και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση των δυσλειτουργιων της στυσεως
AR011919A1 (es) FORMULACIoN EN COMPRIMIDOS O CÁPSULAS PARA TRAGAR DE PARACETAMOL (N-ACETIL-P-AMINOFENOL) Y PROCEDIMIENTO PARA PREPARARLA
HUP9700826A1 (hu) Peptikus fekély elleni gyógyászati készítmények
TW200505436A (en) Modified release pharmaceutical compositions and the processes for preparing them
IL148003A0 (en) Floating pharmaceutical composition comprising an active phase and a non-active phase
UA89349C2 (uk) Таблетка без покриття, яка містить оланзапін, та спосіб її одержання
GEP20043377B (en) Pharmaceutical Complex

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM OS ARTIGOS 8O, 11 E 13 DA LPI.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.